Lantheus Medical Imaging, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$8.5Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
6,247clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Derace Schaffer | Rochester, NY | Diagnostic Radiology | $2,134,743.89 |
| James Thrall | Boston, MA | Nuclear Radiology | $1,588,603.32 |
| Eyal Herzog | New York, NY | Cardiovascular Disease | $631,041.63 |
| Phuong Khanh Morrow | Houston, TX | Medical Oncology | $351,695.95 |
| Frederick Robertson | Madison, WI | Anesthesiology | $337,635.38 |
| Steven Mottl | Tucson, AZ | Cardiovascular Disease | $328,099.27 |
| Robert Biederman | Charleston, SC | Cardiovascular Disease | $234,849.51 |
| Rajesh Janardhanan | Tucson, AZ | Internal Medicine | $219,056.62 |
| Robert Fowles | Salt Lake City, UT | Cardiovascular Disease | $184,824.10 |
| Paul Bhella | Grapevine, TX | Cardiovascular Disease | $184,585.12 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.